MTF / EMF Research Grant

For Junior Medical Toxicology Faculty, Medical Toxicology Fellows & Emergency Medicine Residents

Quick Info

Amount:
$20,000

Number of Grants Available:
One

Funding Duration:
1 year

Next Application Deadline:
January 20, 2023

More Information & Submit

Award Overview

The Medical Toxicology Foundation (MTF) endeavors to support Medical Toxicology research. The MTF/EMF Research Award is jointly sponsored by the Medical Toxicology Foundation and the Emergency Medicine Foundation (EMF).

The goals of the grant offering are: 1) to promote toxicology-related research; 2) to advance emergency toxicology care; and 3) to facilitate the academic growth and development of future researchers in emergency medicine and toxicology by investing in the future of the specialty of emergency medicine and its subboards.

Eligibility

This grant is available to any physician who will be enrolled as a resident or Medical Toxicology fellow in good standing in an ACGME approved Emergency Medicine residency, Medical Toxicology fellowship, or a fellow in any Emergency Medicine sub-specialty training programs for the proposed funding year. The applicant must have an appropriate Emergency Medicine or Medical Toxicology faculty supervisor. The research award is also open to young Medical Toxicology faculty, those with five years or less faculty career experience. Any part-time junior faculty experience (such as during sub-specialty fellowship training) does not count toward the five-year guideline.

Although not mandatory, proposals utilizing the ACMT Toxicology Investigators Consortium (ToxIC) Registry are particularly encouraged.

Read More About ToxIC

The Toxicology Investigators Consortium (ToxIC) is a multicenter toxicosurveillance and research network developed to detect new and emerging drugs of abuse, adverse effects of new medications in the post-marketing phase, and emerging toxicological threats.

Our projects include case registry design and maintenance, led by ToxIC’s medical toxicology physician leadership and registry experts on staff. Each case registry is tailored to collect detailed clinical data, such as the patient demographics, medical and social history, circumstances of exposure, symptoms, treatments administered, and the patient outcome. Toxicological data is therefore gathered by trained medical toxicology physicians who are skilled in the subtle signs of toxicity and poisoning, leading to a high quality case registry. 

Visit the ToxIC Website

Previous Recipients

Daniel Nogee, MD
Yale New Haven Hospital
Award Amount: $10,000

Abstract: Winner of the 2019 ASM Shark Tank for his presentation, “Machine Learning Enhanced Diagnosis of Toxic Exposures”

Dalia Alwasiyah, MD
Carolinas Medical Center
“Urinary Gadolinium Levels: A Possible Indicator of Long-Term Retention after Contrast Enhanced MRIs”
Award Amount: $10,000
Mentor: Michael Beuhler, MD

Abstract: Alwasiyah, D., Murphy, C., Jannetto, P., Hogg, M., Beuhler, M. Urinary Gadolinium Levels After Contrast Enhanced MRI in Individuals with Normal Renal Function. J. Med. Toxicol. (2019) 15: 53.

Publication: Alwasiyah, D., Murphy, C., Jannetto, P. et al. Urinary Gadolinium Levels After Contrast-Enhanced MRI in Individuals with Normal Renal Function: a Pilot Study J. Med. Toxicol. (2019) 15: 121.

Christina Nussbaum, MD
Brody School of Medicine, East Carolina University
“Naltrexone as an antidote to prevent delayed neuropsychological disabilities from acute poisoning with the sarin analogue diisopropylfluorophosphate”
Award Amount: $10,000
Mentor: William Meggs, MD

Abstract: Nussbaum C, Meggs W, Brewer K, Fletcher P, Jr., Tran T, O’Rourke D, Dewitt J. Naltrexone as an Antidote to Prevent Delayed Neuropsychological Disabilities from Acute Poisoning With the Sarin Analogue Diisopropylfluorophosphate. Annals of Emergency Medicine 2017; 70:138 (Abstract 350).

Lindsay Fox, MD
Icahn School of Medicine at Mount Sinai
“Understanding Relationships Between Opioid Prescribing, Patient Characteristics, and Overdose”
Award Amount: $5,000
Mentor: Alex Manini, MD

Abstracts:

  • Fox LM, Gestal C, Jalloh Y, Harper-Brooks A, Beicer A, Manini AF. Survey of prescription opioid knowledge and use patterns among ED patients that were prescribed opioid medications. Clin. Tox. 2016; 54:8.
  • Fox LM, Hoffman RS, Vlahov D, Manini AF. Clinical risk factors in emergency department patients with prescription opioid overdose. Acad Emerg Med. 2015; 22: S1.
  • Fox LM, Gestal C, Jalloh Y, Harper-Brooks A, Tapia B, Manini AF. Prescription opioid use and knowledge of overdose prevention strategies among ED patients. J. Med. Toxicol. 2015; 12:3-47 (abstract #86).
  • Fox LM, Hoffman RS, Vlahov D, Manini AF. Clinical Risk Factors in ED Patients with Prescription Opioid Overdose. J. Med. Toxicol. 2015; 11: 2.

Publications:

  • Fox LM, Hoffman RS, Vlahov D, Manini AF. Risk factors for severe respiratory depression from prescription opioid overdose. Addict Abingdon Engl 2017
  • Fox LM, Hoffman RS, Vlahov D, Manini AF. Risk factors for severe respiratory depression from prescription opioid overdose. Addiction. 2018;113(1):59–66. doi:10.1111/add.13925

Jennifer Parker Cote, MD
Brody School of Medicine, East Carolina University
“Efficacy of Trypsin in Treating Coral Snake Envenomation in the Porcine Model”
Award Amount: $5,000
Mentor: William Meggs, MD

Abstract: Parker-Cote JL, O’Rourke D, Brewer KL, Lertpiriyapong K, Girard J, Bush SP, Miller SN, Punja M, Meggs WJ. Efficacy of trypsin in treating coral snake envenomation in the porcine model. J Med Toxicol 2015;11:2

Publication: Parker-Cote JL, O’Rourke D, Brewer KL, Lertpiriyapong K, Girard J, Bush SP, Miller SN, Punja M, Meggs WJ. Efficacy of trypsin in treating coral snake envenomation in the porcine model. J Med Toxicol 2015;11:430-432

James Cao, MD
Carolinas Medical Center
“Point of Care Testing in Setting of Nitromethane and Methanol Co-ingestion Will Not Mask True Creatinine, Anion Gap, or Osmolar Gap”
Award Amount: $5,000
Mentor: Michael Beuhler, MD

Abstracts:

  • Cao D, Maynard SM, Mitchell-Smith AM, Kerns WP, Beuhler MC. Point-of-Care Testing in Setting of Nitromethane and Methanol Co-Ingestion Will Not Mask True Creatinine, Anion Gap, or Osmolar Gap. Journal of Medical Toxicology. 2014;10(1):65-66.
  • Cao D, Maynard SM, Mitchell-Smith AM, Kerns WP, Beuhler MC. Point-of-Care Testing in Setting of Nitromethane and Methanol Co-Ingestion Will Not Mask True Creatinine, Anion Gap, or Osmolar Gap. Ann Emerg Med 2013;62:S42-S43.

Publication: Cao D, Maynard S, Mitchell AM, Kerns WP, Beuhler M. Point of care testing provides an accurate measurement of creatinine, anion gap, and osmolal gap in ex-vivo whole blood samples with nitromethane. Clin Toxicol 2014;52:611-617